Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir

Nguyen E, Trinh S, Trinh H, et al. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Aliment Pharmacol Ther. 2019;49(1):99-106.

Publication Type:

Journal Article

Authors:

Nguyen, E; Trinh, S; Trinh, H; et, al

Source:

Aliment Pharmacol Ther, Volume 49, Issue 1, p.99-106 (2019)

Cited On:

Treatment-Naive Genotype 5 or 6

Export Citation:

RIS Format

Top